“Clinical Lasting Response of Crizotinib in ALK Positive Lung Squamous Cell Carcinoma With Brain Metastasis”. 2017. European Journal of Oncology and Environmental Health 22 (2): 95-97. https://mattioli1885journals.com/index.php/EJOEH/article/view/4800.